S. Karger AG

SHERPA: Unknown

People

  1. Motzer
    Motzer
  2. De La Cruz
    De La Cruz
  3. De Stanchina
    De Stanchina
  4. Gany
    Gany
  5. Gonzalez
    Gonzalez
  6. Hamilton
    Hamilton
  7. Hay
    Hay
  8. Koche
    Koche
  9. Mauro
    Mauro
  10. Patel
    Patel

Groups

  1. Department of Medicine (14)
  2. Solid Tumor Oncology Division (10)
  3. Genitourinary Oncology Service (4)
  4. Hematologic Malignancies, Division of (4)
  5. Center for Hematologic Malignancies (3)
  6. Survivorship Research (3)
  7. Adult Leukemia (2)
  8. GSK Faculty (2)
  9. Molecular Imaging and Therapy Service (2)
  10. Population Sciences Research Program (2)
Search Within
  1. "2016"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (8)
Groups
  1. Department of Medicine (14)
  2. Solid Tumor Oncology Division (10)
  3. Genitourinary Oncology Service (4)
  4. Hematologic Malignancies, Division of (4)
  5. Center for Hematologic Malignancies (3)
  6. Survivorship Research (3)

More Groups

People
  1. Robert Motzer (3)
  2. Wolfgang Weber (2)
  3. Amit Sinha (1)
  4. Aniruddha Deshpande (1)
  5. Anthony De La Cruz (1)
  6. Carlos Gonzalez (1)

More People

Years
  1. 2016 (22)
Publications
  1. Oncology Research and Treatment (12)
  2. Neuroendocrinology (4)
  3. Acta Haematologica (2)
  4. Dermatology (1)
  5. Hormone Research in Paediatrics (1)
  6. Oncology (1)

More Publications

Results (22)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Primary ovarian insufficiency in childhood cancer survivors: A report from the St Jude Lifetime Cohort (SJLIFE)
    Meeting Abstract

    Chemaitilly, W.; Li, Z.; Krasin, M.; Wilson, C.; Green, D.; Klosky, J.; Barnes, N.; Clark, K.; Frenandez-Pineda, I.; Metzger, M.; more...
    Hormone Research in Paediatrics (2016)

    Fulltext@MSK | Save
  • Nivolumab monotherapy in metastatic urothelial cancer (mUC): Efficacy (by PD-L1 expression) and safety results from the CheckMate 032 study
    Meeting Abstract

    Jaeger, D.; Sharma, P.; Bono, P.; Kim, J.; Spiliopoulou, P.; Calvo, E.; Pillai, R. N.; Ott, P. A.; de Braud, F.; Morse, M.; more...
    Oncology Research and Treatment (2016)

    Fulltext@MSK | Save
  • Recognizing symptom burden in advanced prostate cancer: A global patient and caregiver survey
    Meeting Abstract

    Schostak, M.; Oh, W. K.; Tombal, B.; Delacruz, A.; Tomlinson, I.; Ripley, A. V.; Drudge-Coates, L.; Mastris, K.; O'Sullivan, J. M.; Shore, N. D.
    Oncology Research and Treatment (2016)

    Fulltext@MSK | Save
  • A novel hereditary pancreatic neuroendocrine tumor syndrome associated with biallelic inactivation of the glucagon receptor
    Meeting Abstract

    Tang, L.; Yu, R.
    Neuroendocrinology (2016)

    Fulltext@MSK | Save
  • Design of a phase 3, international, prospective, randomized, double-blind, placebo (PBO) controlled study assessing efficacy and safety of lanreotide autogel/depot (LAN) 120 mg in patients with well-differentiated, advanced typical and atypical lung NETs
    Meeting Abstract

    Reidy-Lagunes, D.; Kulke, M.; Wolin, E.; Mirakhur, B.; Massien, C.; Caplin, M.; Baudin, E.
    Neuroendocrinology (2016)

    Fulltext@MSK | Save
  • CheckMate 017 and 057 studies of nivolumab vs docetaxel in patients with advanced NSCLC: 2-year-update and exploratory cytokine profile analyses
    Meeting Abstract

    Eberhardt, W. E. E.; Borghaei, H.; Brahmer, J. R.; Horn, L.; Ready, N.; Steins, M.; Felip, E.; Paz-Ares, L. G.; Arrieta, O.; Barlesi, F.; more...
    Oncology Research and Treatment (2016)

    Fulltext@MSK | Save
  • Correlation of response with overall survival (OS) for nivolumab vs everolimus in advanced renal cell carcinoma (aRCC): Results from the phase III CheckMate 025 study
    Meeting Abstract

    Grünwald, V.; Motzer, R. J.; Sharma, P.; Escudier, B.; McDermott, D. F.; George, S.; Srinivas, S.; Tykodi, S. S.; Sosman, J. A.; Plimack, E. R.; more...
    Oncology Research and Treatment (2016)

    Fulltext@MSK | Save
  • Improvements in quality of life and overall survival in patients with advanced renal cell carcinoma treated with nivolumab vs everolimus in the phase Ill CheckMate 025 study
    Meeting Abstract

    Grünwald, V.; Cella, D.; Nathan, P.; Doan, J.; Dastahi, H.; Taylor, F.; Bennett, B.; DeRosa, M.; Berry, S.; Broglio, K.; more...
    Oncology Research and Treatment (2016)

    Fulltext@MSK | Save
  • Synergistic inhibition of chromatin modifiers reverses a leukemogenic gene expression program in NPM1 mutant leukemia
    Meeting Abstract

    Kühn, M. W. M.; Song, E.; Feng, Z.; Sinha, A.; Chen, C. W.; Deshpande, A. J.; Cusan, M.; Farnoud, N. R.; Koche, R. P.; Bradner, J. E.; more...
    Oncology Research and Treatment (2016)

    Fulltext@MSK | Save
  • Telomere length recovery: A strong predictor of overall survival in acute promyelocytic leukemia
    Journal Article

    Baljevic, M.; Dumitriu, B.; Lee, J. W.; Paietta, E. M.; Wiernik, P. H.; Racevskis, J.; Chen, C.; Stein, E. M.; Gallagher, R. E.; Rowe, J. M.; more...
    Acta Haematologica (2016)

    Fulltext@MSK | Save